Dippel, Franz-Werner

Sanofi-Aventis Deutschland GmbH

Publikationen

• Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin.
• Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin.
• Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin.